Cozza G - Search Results

1

A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.

Kalathur M, Toso A, Chen J, Revandkar A, Danzer-Baltzer C, Guccini I, Alajati A, Sarti M, Pinton S, Brambilla L, Di Mitri D, Carbone G, Garcia-Escudero R, Padova A, Magnoni L, Tarditi A, Maccari L, Malusa F, Kalathur RK, A Pinna L, Cozza G, Ruzzene M, Delaleu N, Catapano CV, Frew IJ, Alimonti A. Kalathur M, et al. Among authors: cozza g. Nat Commun. 2015 Jun 18;6:7227. doi: 10.1038/ncomms8227. Nat Commun. 2015. PMID: 26085373 Free article.

2

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.

Meggio F, Pagano MA, Moro S, Zagotto G, Ruzzene M, Sarno S, Cozza G, Bain J, Elliott M, Deana AD, Brunati AM, Pinna LA. Meggio F, et al. Among authors: cozza g. Biochemistry. 2004 Oct 12;43(40):12931-6. doi: 10.1021/bi048999g. Biochemistry. 2004. PMID: 15461466 Free article.

3

Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors.

Pagano MA, Poletto G, Di Maira G, Cozza G, Ruzzene M, Sarno S, Bain J, Elliott M, Moro S, Zagotto G, Meggio F, Pinna LA. Pagano MA, et al. Among authors: cozza g. Chembiochem. 2007 Jan 2;8(1):129-39. doi: 10.1002/cbic.200600293. Chembiochem. 2007. PMID: 17133643

4

The selectivity of inhibitors of protein kinase CK2: an update.

Pagano MA, Bain J, Kazimierczuk Z, Sarno S, Ruzzene M, Di Maira G, Elliott M, Orzeszko A, Cozza G, Meggio F, Pinna LA. Pagano MA, et al. Among authors: cozza g. Biochem J. 2008 Nov 1;415(3):353-65. doi: 10.1042/BJ20080309. Biochem J. 2008. PMID: 18588507

5

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.

Cozza G, Mazzorana M, Papinutto E, Bain J, Elliott M, di Maira G, Gianoncelli A, Pagano MA, Sarno S, Ruzzene M, Battistutta R, Meggio F, Moro S, Zagotto G, Pinna LA. Cozza G, et al. Biochem J. 2009 Jul 15;421(3):387-95. doi: 10.1042/BJ20090069. Biochem J. 2009. PMID: 19432557

6

The dark side of protein kinase CK2 inhibition.

Cozza G, Meggio F, Moro S. Cozza G, et al. Curr Med Chem. 2011;18(19):2867-84. doi: 10.2174/092986711796150423. Curr Med Chem. 2011. PMID: 21651492 Review.

7

Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A.

Sarno S, Mazzorana M, Traynor R, Ruzzene M, Cozza G, Pagano MA, Meggio F, Zagotto G, Battistutta R, Pinna LA. Sarno S, et al. Among authors: cozza g. Cell Mol Life Sci. 2012 Feb;69(3):449-60. doi: 10.1007/s00018-011-0758-7. Epub 2011 Jul 1. Cell Mol Life Sci. 2012. PMID: 21720886 Free PMC article.

8

Protein kinase CK2 inhibitors: a patent review.

Cozza G, Pinna LA, Moro S. Cozza G, et al. Expert Opin Ther Pat. 2012 Sep;22(9):1081-97. doi: 10.1517/13543776.2012.717615. Expert Opin Ther Pat. 2012. PMID: 22908959 Review.

9

Kinase CK2 inhibition: an update.

Cozza G, Pinna LA, Moro S. Cozza G, et al. Curr Med Chem. 2013;20(5):671-93. doi: 10.2174/092986713804999312. Curr Med Chem. 2013. PMID: 23210774 Review.

10

Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.

Cozza G, Sarno S, Ruzzene M, Girardi C, Orzeszko A, Kazimierczuk Z, Zagotto G, Bonaiuto E, Di Paolo ML, Pinna LA. Cozza G, et al. Biochim Biophys Acta. 2013 Jul;1834(7):1402-9. doi: 10.1016/j.bbapap.2013.01.018. Epub 2013 Jan 27. Biochim Biophys Acta. 2013. PMID: 23360763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page